AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
CAMBRIDGE, England AstraZeneca, working with genome pioneer Craig Venter, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines. The initiative, anno... More »
